India's pharma exports cross $30B in FY25, record surge seen in March

In a remarkable milestone, India’s yearly drug and pharmaceutical exports reached an all-time high of $30 billion in Fiscal Year 2025, fueled by a 31 percent increase compared to the previous year in March...

Eli Lilly's Pill Cuts 7.9% Weight in Diabetes Patients, Study Finds

Eli Lilly’s experimental weight-loss pill, orforglipron, achieved nearly 8% weight loss and notable blood sugar reduction in a late-stage trial for patients with type 2 diabetes. The once-daily oral drug exceeded Wall Street expectations, triggering

Zydus Medtech, Braile Biomedica announce global pact to commercialise TAVI

Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited specializing in medical technology development, has entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda...

Indian Pharma Targets New Markets to Offset US Sales Decline

To protect their growth in turbidity, Indian pharmaceutical companies, especially the smaller and mid-sized players, are now swinging their attention to...

Fortis Launches Institute of Genomic Medicine to Transform Healthcare

Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle...

Alembic Receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg

Alembic Pharmaceuticals Limited (Alembic) has received from the U.S. Food and Drug Administration (U.S. FDA), final approval for its ANDA application for...

India Revises Pharma Import Monitoring Fees to Boost Compliance

The Foreign Trade Policy (FTP) 2023's Appendix 2K has been updated by the Directorate General of Foreign Trade (DGFT), requiring pharmaceutical imports and exports to pay a registration fee through the Import Monitoring System (IMS). The objective o

Health Ministry limits use of common cold meds for kids below four years

The Union Health Ministry hereby prohibits the use of cold FDC Chlorpheniramine Maleate 2 mg and Phenylephrine Hydrochloride 5 mg per ml drops in children below the...

Venus Remedies' Polymyxin B Gets US FDA QIDP Designation

The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....

India's $10B pharma exports to US face probe amid rising trade tensions

India's pharmaceutical exports to the United States, which amount to nearly $10 billion each year, may face challenges as the US government has commenced an investigation

© 2025 India Pharma Outlook. All Rights Reserved.